The studies that characterize the impact of azithromycin on IL-17-mediated pathology in lymphocyte-driven airway inflammation in BOS and influenza infection suggest promise associated with this mechanism (48, 50, 52, 61). The gene discussed is IL17A; the disease is Buschke-Ollendorff syndrome.